← Leaderboards
Michael Shtutman
University Of South Carolina At Columbia
$3,559,355
Attributed
$5,685,381
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $827K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,685,381 · 7
By mechanism
R01$2,115,541 · 1
P20$2,012,986 · 2
R21$809,056 · 2
P30$454,798 · 1
R03$293,000 · 1
Top collaborators
- Michael D Wyatt7 shared
- Ilya Safro5 shared
- Shawn Scott Sutton5 shared
- Rosemarie M Booze2 shared
- Norma Frizzell2 shared
- Jun Zhu2 shared
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Ilya Safro$528,885
- Shawn Scott Sutton$528,885
- Michael D Wyatt$3,777,677
- Norma Frizzell$3,422,646
- Christine Ebert$1,403,265
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesProteinsProgramsCellsGenerationsFunctional GenomicsGene ExpressionResearch PersonnelValidationOverexpressionPhenotypeBaseCell LinePharmaceutical PreparationsData AnalysesTargeted TreatmentNeuronsCocaineDrug Of AbuseAffectHiv InfectionsAnimalsGene Expression ProfilingGenetic Transcription
Grant awards (23)
Knowledge discovery and machine learning to elucidate the mechanisms of HIV activity and interaction with substance use disorder$417,864
R01 · FY2025 · DA · contact PI
Functional Genomics Core$227,399
P30 · FY2025 · GM · contact PI
Knowledge discovery and machine learning to elucidate the mechanisms of HIV activity and interaction with substance use disorder$417,864
R01 · FY2024 · DA · contact PI
Functional Genomics Core$227,399
P30 · FY2024 · GM · contact PI
Targeting Immunometabolism: a novel role for itaconate in the treatment of HIV-associated neurocognitive disorder and cocaine use disorder$181,708
R21 · FY2024 · DA · contact PI
Knowledge discovery and machine learning to elucidate the mechanisms of HIV activity and interaction with substance use disorder$417,864
R01 · FY2023 · DA · contact PI
Targeting Immunometabolism: a novel role for itaconate in the treatment of HIV-associated neurocognitive disorder and cocaine use disorder$219,090
R21 · FY2023 · DA · contact PI
Functional Genomics Core$177,330
P20 · FY2023 · GM · contact PI
Knowledge discovery and machine learning to elucidate the mechanisms of HIV activity and interaction with substance use disorder$417,864
R01 · FY2022 · DA · contact PI
Functional Genomics Core$194,075
P20 · FY2022 · GM · contact PI
Knowledge discovery and machine learning to elucidate the mechanisms of HIV activity and interaction with substance use disorder$444,085
R01 · FY2021 · DA · contact PI
Functional Genomics Core$188,250
P20 · FY2021 · GM · contact PI
Functional Genomics Core$188,251
P20 · FY2020 · GM · contact PI
Impact of Dead Box RNA Helicase 3 signaling on HIV-1 Tat- and cocaine-induced neurotoxicity$185,493
R21 · FY2020 · DA · contact PI
Impact of Dead Box RNA Helicase 3 signaling on HIV-1 Tat- and cocaine-induced neurotoxicity$222,765
R21 · FY2019 · DA · contact PI
Functional Genomics Core$188,251
P20 · FY2019 · GM · contact PI
Targeting COPZl in miR-152 deficient tumor cells$214,170
P20 · FY2018 · GM · contact PI
Functional identification of new mechanisms of neurotoxicity induced by HIV and drugs of abuse$146,500
R03 · FY2018 · DA · contact PI
Targeting COPZl in miR-152 deficient tumor cells$217,202
P20 · FY2017 · GM · contact PI
Functional identification of new mechanisms of neurotoxicity induced by HIV and drugs of abuse$146,500
R03 · FY2017 · DA · contact PI
Targeting COPZl in miR-152 deficient tumor cells$217,117
P20 · FY2016 · GM · contact PI
Targeting COPZl in miR-152 deficient tumor cells$214,170
P20 · FY2015 · GM · contact PI
Targeting COPZl in miR-152 deficient tumor cells$214,170
P20 · FY2014 · GM · contact PI